Testing effectiveness (Phase 2)Study completedNCT00064363
What this trial is testing
Talampanel in Treating Patients With Recurrent High-Grade Glioma
Who this might be right for
Brain and Central Nervous System Tumors
National Institutes of Health Clinical Center (CC)